KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) EBT Margin: 2010-2024

Historic EBT Margin for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to -13.69%.

  • Emergent BioSolutions' EBT Margin fell 2354.00% to 24.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.42%, marking a year-over-year increase of 3186.00%. This contributed to the annual value of -13.69% for FY2024, which is 5599.00% up from last year.
  • As of FY2024, Emergent BioSolutions' EBT Margin stood at -13.69%, which was up 80.35% from -69.68% recorded in FY2023.
  • Emergent BioSolutions' EBT Margin's 5-year high stood at 26.11% during FY2020, with a 5-year trough of -69.68% in FY2023.
  • Its 3-year average for EBT Margin is -34.32%, with a median of -19.60% in 2022.
  • Per our database at Business Quant, Emergent BioSolutions' EBT Margin slumped by 5,009bps in 2023 and then surged by 5,599bps in 2024.
  • Emergent BioSolutions' EBT Margin (Yearly) stood at 26.11% in 2020, then plummeted by 902bps to 17.10% in 2021, then plummeted by 3,669bps to -19.60% in 2022, then slumped by 5,009bps to -69.68% in 2023, then soared by 5,599bps to -13.69% in 2024.